Nexstim, a Finland-based developer of non-invasive brain diagnostic and therapy technologies, has extended its latest round by €2m ($3m) after backing from a European financial investor.
Capricorn Health-tech Fund provided the money as a new investor and took the round total to €13.4m.
It joined a consortium including Lundbeckfond Ventures, the quasi-corporate venturing unit of Denmark-based Lundbeck Foundation, pension fund Ilmarinen, venture capital firms HealthCap and LSP (Life Sciences Partners), and state-backed Sitra, which is the Finnish Innovation…
